These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6982480)

  • 41. Human Y-79 retinoblastoma cells exhibit specific corticotropin-releasing hormone binding sites.
    Olianas MC; Lampis G; Onali P
    J Neurochem; 1995 Jan; 64(1):402-7. PubMed ID: 7798938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM; Fisher LA
    J Auton Nerv Syst; 1991 Jul; 35(1):43-51. PubMed ID: 1940026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats.
    Broccardo M; Improta G
    Eur J Pharmacol; 1990 Jul; 182(2):357-62. PubMed ID: 2397746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
    Yasuda Y; Yasuda N
    Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells.
    Fazal N; Slominski A; Choudhry MA; Wei ET; Sayeed MM
    FEBS Lett; 1998 Sep; 435(2-3):187-90. PubMed ID: 9762905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
    Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC; Mimassi N; Lancien F; Mabin D; Conlon JM
    Gen Comp Endocrinol; 2006 Mar; 146(1):56-61. PubMed ID: 16386738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake.
    Gosnell BA; Morley JE; Levine AS
    Pharmacol Biochem Behav; 1983 Nov; 19(5):771-5. PubMed ID: 6359178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians.
    Stenzel-Poore MP; Heldwein KA; Stenzel P; Lee S; Vale WW
    Mol Endocrinol; 1992 Oct; 6(10):1716-24. PubMed ID: 1448118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a specific and a nonspecific vasodilator on regional blood flows in experimental heart failure.
    MacCannell KL; Giraud GD; Lederis K; Hamilton PL; Groves G
    Can J Physiol Pharmacol; 1982 Feb; 60(2):174-83. PubMed ID: 7083066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural evolution of urotensin-I: reflections of life before corticotropin releasing factor.
    Lovejoy DA
    Gen Comp Endocrinol; 2009 Oct; 164(1):15-9. PubMed ID: 19393654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urotensin I-CRF-Urocortins: a mermaid's tail.
    Pittman QJ; Hollenberg MD
    Gen Comp Endocrinol; 2009 Oct; 164(1):7-14. PubMed ID: 19409389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central hyperventilatory action of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    Gen Comp Endocrinol; 2009 Oct; 164(1):51-60. PubMed ID: 19341734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
    Boorse GC; Denver RJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sauvagine analogs selective for corticotropin releasing factor 2 receptor: effect of substitutions at positions 35 and 39 on CRF2R selectivity.
    Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ
    Peptides; 2005 May; 26(5):887-91. PubMed ID: 15808919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.
    Affolter JT; Newby DE; Wilkinson IB; Winter MJ; Balment RJ; Webb DJ
    Br J Clin Pharmacol; 2002 Dec; 54(6):617-21. PubMed ID: 12492609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.